Clinical & Diagnostic
HKSH Medical Group And Shenzhen Cancer Hospital Formalise Proton Therapy Collaboration Under Healthy China 2030 Framework
In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, HKSH Medical Group ("HKSH")...
December 25, 2025 | News
NeuroSense Reports Clean Safety Profile From Phase 2 PrimeC Study In Alzheimer’s Disease
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for&nbs...
December 24, 2025 | News
Ginkgo Bioworks Joins Carnegie Mellon Led ARPA H Programme To Advance At Home Cancer Detection
Ginkgo Bioworks announced its partnership with Carnegie-Mellon University (CMU) for an award by the Advanced Research Projects Agency for Health...
December 24, 2025 | News
Japan Approves Guardant360 CDx As First Blood Based Companion Diagnostic For ESR1 Mutations In Breast Cancer
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-posit...
December 23, 2025 | News
Japan Approves Incyte’s Zynyz As First Line Treatment For Advanced Anal Canal Cancer
Incyte Biosciences Japan G.K. announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination w...
December 23, 2025 | News
Merck Secures World First Regulatory Approval For Pimicotinib In Rare Joint Tumour TGCT In China
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantl...
December 23, 2025 | News
Meiji Seika Pharma Partners With MBC BioLabs To Strengthen Global Biotech Innovation
-Meiji Seika Pharma Co., Ltd. announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting ...
December 22, 2025 | News
Ferronova Raises $6 Million To Advance Nanoparticle Guided Cancer Surgery Technology
Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solut...
December 18, 2025 | News
Atom Therapeutics Secures FDA Approval To Advance Phase II Trial Of ABP 745 In Atherosclerosis
Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA ...
December 18, 2025 | News
Sanofi And Dren Bio Expand Strategic Collaboration To Advance Next Generation B Cell Depleting Therapies In Autoimmune Disease
– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engag...
December 17, 2025 | News
GenSci, RTW And Yarrow Forge US Focused Biotech Partnership To Advance First In Class Thyroid Autoimmune Therapy
Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology di...
December 17, 2025 | News
ALZpath Licenses pTau217 Antibody To Siemens Healthineers To Expand Blood Based Alzheimer’s Diagnostics
ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer’s disease and related dementias, announced a licensing ag...
December 17, 2025 | News
Sobi To Acquire Arthrosi Therapeutics In Up To $1.5 Billion Deal
Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which w...
December 16, 2025 | News
Akeso Secures FDA Clearance to Launch Global Phase III Gastric Cancer Trial of Cadonilimab
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in ...
December 15, 2025 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
